BPC-157 may not fit research involving: Purely structural muscle wasting (where cell migration is the primary bottleneck, not blood flow) Models where rapid angiogenesis is contraindicated (e.g., certain tumor models) TB-500 may not fit research involving: Gastrointestinal rescue or leaky gut models (it has no known direct affinity for GI tissue repair) Tendon-to-bone insertions (BPC-157 shows superior efficacy here due to its effect on bone collagen) Common Mistakes Mistake: Expecting either peptide to act like an anabolic steroid
En fuente abierta, PubChem (CID 9941957) lista para BPC-157 la frmula molecular C62H98N16O22
The disclosure also contemplates the use of one or more of the formulations or compositions, in the manufacture of medicaments for treating, abating, reducing, or ameliorating the symptoms of a disease, dysfunction, or disorder in a mammal, such as a human that has, is suspected of having, or at risk for developing an auris interna disorder
Page MJ, McKenzie JE, Bossuyt PM, et al
Layden AJ, Tse K, Finkelstein JL
BPC-157 is a 15-amino acid synthetic peptide derived from a naturally occurring protein found in human gastric juice